|
GB8909891D0
(en)
*
|
1989-04-28 |
1989-06-14 |
Riker Laboratories Inc |
Device
|
|
GB9004781D0
(en)
*
|
1990-03-02 |
1990-04-25 |
Glaxo Group Ltd |
Device
|
|
MY105368A
(en)
*
|
1990-03-02 |
1994-09-30 |
Glaxo Group Ltd |
Inhalation device.
|
|
SK280968B6
(sk)
*
|
1990-03-02 |
2000-10-09 |
Glaxo Group Limited |
Balenie medikamentu na použite v inhalačnom prístroji
|
|
US6536427B2
(en)
*
|
1990-03-02 |
2003-03-25 |
Glaxo Group Limited |
Inhalation device
|
|
FR2667509B1
(fr)
*
|
1990-10-04 |
1995-08-25 |
Valois |
Inhalateur a poudre, dispositif de conditionnement de microdoses de poudre sous forme de bandes adaptees a etre utilisees dans un inhalateur a poudre, et procede de fabrication de ces bandes.
|
|
AU677222B2
(en)
*
|
1992-09-11 |
1997-04-17 |
Glaxo Group Limited |
Inhalation device
|
|
SE9203570D0
(sv)
*
|
1992-11-27 |
1992-11-27 |
Astra Ab |
Inhaler for multiple use
|
|
US5896855A
(en)
*
|
1992-12-24 |
1999-04-27 |
Rhone-Poulenc Rorer Limited |
Multi dose inhaler apparatus
|
|
PT806214E
(pt)
*
|
1992-12-24 |
2002-05-31 |
Aventis Pharma Ltd |
Dispositivo inalador
|
|
GB9326574D0
(en)
*
|
1993-12-31 |
1994-03-02 |
King S College London |
Dry power inhalers
|
|
JPH07219571A
(ja)
*
|
1994-01-31 |
1995-08-18 |
Yukihiko Takino |
カラオケ曲目表示装置
|
|
PT101450B
(pt)
*
|
1994-02-02 |
1999-11-30 |
Hovione Produtos Farmaceuticos |
Novo dispositivo para inalacao
|
|
GB9417399D0
(en)
|
1994-08-30 |
1994-10-19 |
Scherer Corp R P |
Ocular treatment device
|
|
ATE251433T1
(de)
*
|
1994-08-30 |
2003-10-15 |
Pharmacia Ab |
Verpackung für flüssigen dosen, augenbehandlungsvorrichtung und ihre verwendung
|
|
DE29501527U1
(de)
*
|
1995-02-01 |
1995-03-30 |
Hugo Kern und Liebers GmbH & Co. Platinen- und Federnfabrik, 78713 Schramberg |
Vorrichtung zur Erzeugung inhalierbarer Wirkstoffpartikel
|
|
US5622166A
(en)
*
|
1995-04-24 |
1997-04-22 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler delivery system
|
|
US5921237A
(en)
*
|
1995-04-24 |
1999-07-13 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler
|
|
SE9503344D0
(sv)
*
|
1995-09-27 |
1995-09-27 |
Astra Ab |
Inhalation device
|
|
EA001237B1
(ru)
|
1996-01-03 |
2000-12-25 |
Глаксо Груп Лимитед |
Ингаляционное устройство
|
|
USD395499S
(en)
|
1996-04-08 |
1998-06-23 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler
|
|
US5857456A
(en)
*
|
1996-06-10 |
1999-01-12 |
Sarnoff Corporation |
Inhaler apparatus with an electronic means for enhanced release of dry powders
|
|
US5871010A
(en)
|
1996-06-10 |
1999-02-16 |
Sarnoff Corporation |
Inhaler apparatus with modified surfaces for enhanced release of dry powders
|
|
GB9626233D0
(en)
*
|
1996-12-18 |
1997-02-05 |
Chawla Brinda P S |
Medicament packaging and deliveery device
|
|
SE9700424D0
(sv)
*
|
1997-02-07 |
1997-02-07 |
Astra Ab |
Powder inhaler
|
|
US6006747A
(en)
*
|
1997-03-20 |
1999-12-28 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler
|
|
SE9702796D0
(sv)
*
|
1997-07-25 |
1997-07-25 |
Pharmacia & Upjohn Ab |
A device at a pharmaceutical container or inhaler
|
|
CA2212430A1
(en)
|
1997-08-07 |
1999-02-07 |
George Volgyesi |
Inhalation device
|
|
US20060165606A1
(en)
*
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
|
US5954047A
(en)
*
|
1997-10-17 |
1999-09-21 |
Systemic Pulmonary Development, Ltd. |
Methods and apparatus for delivering aerosolized medication
|
|
GB9722285D0
(en)
*
|
1997-10-23 |
1997-12-17 |
Rhone Poulenc Rorer Ltd |
Inhalation device
|
|
USD412978S
(en)
|
1997-12-02 |
1999-08-17 |
Dura Pharmaceuticals, Inc. |
Inhaler
|
|
US6116238A
(en)
*
|
1997-12-02 |
2000-09-12 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler
|
|
EP1144035B1
(en)
*
|
1999-01-22 |
2005-10-12 |
Glaxo Group Limited |
Inhalation device
|
|
GB9905538D0
(en)
|
1999-03-10 |
1999-05-05 |
Glaxo Group Ltd |
A device
|
|
US6601729B1
(en)
|
1999-03-26 |
2003-08-05 |
Papp Enterprises, Llc |
Automated portable medication radial dispensing apparatus and method using a carrier tape
|
|
GB9909354D0
(en)
|
1999-04-24 |
1999-06-16 |
Glaxo Group Ltd |
Medicament carrier
|
|
GB9909357D0
(en)
|
1999-04-24 |
1999-06-16 |
Glaxo Group Ltd |
Medicament carrier
|
|
US20100197719A1
(en)
*
|
1999-05-12 |
2010-08-05 |
Boehringer Ingelheim Pharma Kg |
Medicament compositions containing anticholinergically-effective compounds and betamimetics
|
|
US20040002548A1
(en)
*
|
1999-05-12 |
2004-01-01 |
Boehringer Ingelheim Pharma Kg |
Medicament compositions containing anticholinergically-effective compounds and betamimetics
|
|
ES2165768B1
(es)
|
1999-07-14 |
2003-04-01 |
Almirall Prodesfarma Sa |
Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
|
|
US6730066B1
(en)
|
1999-08-03 |
2004-05-04 |
Pharmacia Ab |
Liquid delivery container
|
|
GB9925934D0
(en)
|
1999-11-03 |
1999-12-29 |
Glaxo Group Ltd |
Novel apparatus and process
|
|
US6679256B2
(en)
*
|
1999-12-17 |
2004-01-20 |
Nektar Therapeutics |
Systems and methods for extracting powders from receptacles
|
|
US7171965B2
(en)
*
|
2000-02-01 |
2007-02-06 |
Valois S.A.S. |
Breath actuated dry powder inhaler and tape dose strip
|
|
GB0004456D0
(en)
*
|
2000-02-26 |
2000-04-19 |
Glaxo Group Ltd |
Medicament dispenser
|
|
DE10011120A1
(de)
*
|
2000-03-09 |
2001-09-13 |
Pfeiffer Erich Gmbh & Co Kg |
Spender für Medien
|
|
WO2001072605A1
(en)
*
|
2000-03-27 |
2001-10-04 |
Dura Pharmaceuticals, Inc. |
Containers for individual doses of an inhalable pharmaceutical
|
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
|
US20030003057A1
(en)
*
|
2000-07-07 |
2003-01-02 |
Jeffry Weers |
Methods for administering leuprolide by inhalation
|
|
US8404217B2
(en)
*
|
2000-05-10 |
2013-03-26 |
Novartis Ag |
Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
|
|
CA2382133C
(en)
*
|
2000-05-10 |
2010-11-23 |
Alliance Pharmaceutical Corporation |
Phospholipid-based powders for drug delivery
|
|
GB0012465D0
(en)
*
|
2000-05-24 |
2000-07-12 |
Glaxo Group Ltd |
Monitoring method
|
|
GB0013619D0
(en)
*
|
2000-06-06 |
2000-07-26 |
Glaxo Group Ltd |
Sample container
|
|
GB0014851D0
(en)
*
|
2000-06-16 |
2000-08-09 |
Glaxo Group Ltd |
Novel pharmaceutical formulation
|
|
GB0015034D0
(en)
|
2000-06-21 |
2000-08-09 |
Glaxo Group Ltd |
Inhalation device
|
|
TWI224514B
(en)
*
|
2000-06-23 |
2004-12-01 |
Norton Healthcare Ltd |
Dose metering system for medicament inhaler
|
|
US7080644B2
(en)
*
|
2000-06-28 |
2006-07-25 |
Microdose Technologies, Inc. |
Packaging and delivery of pharmaceuticals and drugs
|
|
BR0112481A
(pt)
*
|
2000-07-15 |
2003-07-22 |
Glaxo Group Ltd |
Dispensador de medicamentos, kit de partes, e, sistema
|
|
US20020106368A1
(en)
*
|
2000-07-28 |
2002-08-08 |
Adrian Bot |
Novel methods and compositions to upregulate, redirect or limit immune responses to peptides, proteins and other bioactive compounds and vectors expressing the same
|
|
US6759398B2
(en)
|
2000-08-05 |
2004-07-06 |
Smithkline Beecham Corporation |
Anti-inflammatory androstane derivative
|
|
CO5310534A1
(es)
|
2000-08-05 |
2003-08-29 |
Glaxo Group Ltd |
Nuevos derivados de androstano anti-inflamatorios
|
|
AU2001283546A1
(en)
|
2000-08-14 |
2002-02-25 |
Advanced Inhalation Research, Inc. |
Inhalation device and method
|
|
AUPR020400A0
(en)
*
|
2000-09-19 |
2000-10-12 |
Glaxo Wellcome Australia Ltd |
Inhalation device
|
|
GB0026647D0
(en)
*
|
2000-10-31 |
2000-12-13 |
Glaxo Group Ltd |
Medicament dispenser
|
|
US20110301569A1
(en)
|
2001-01-20 |
2011-12-08 |
Gordon Wayne Dyer |
Methods and apparatus for the CVCS
|
|
GB0103630D0
(en)
|
2001-02-14 |
2001-03-28 |
Glaxo Group Ltd |
Chemical compounds
|
|
ES2296923T3
(es)
|
2001-03-22 |
2008-05-01 |
Glaxo Group Limited |
Derivados formanilidas como agonistas del adrenorreceptor beta2.
|
|
US6766799B2
(en)
*
|
2001-04-16 |
2004-07-27 |
Advanced Inhalation Research, Inc. |
Inhalation device
|
|
ES2314052T3
(es)
|
2001-04-30 |
2009-03-16 |
Glaxo Group Limited |
Derivados de ester de 17beta-carbotioato de androstano con un grupo ester ciclico en la posicion 17alfa.
|
|
US20030051728A1
(en)
*
|
2001-06-05 |
2003-03-20 |
Lloyd Peter M. |
Method and device for delivering a physiologically active compound
|
|
FI20011317A0
(fi)
*
|
2001-06-20 |
2001-06-20 |
Orion Corp |
Jauheinhalaattori
|
|
EP1416990A1
(en)
*
|
2001-08-09 |
2004-05-12 |
Glaxo Group Limited |
Inhalation device with a pharmaceutical composition
|
|
MXPA04002405A
(es)
|
2001-09-14 |
2004-05-31 |
Glaxo Group Limetd |
Derivados de fenetanolamina para tratamiento de enfermedades respiratorias.
|
|
EP1487417A4
(en)
|
2001-09-17 |
2010-03-17 |
Glaxo Group Ltd |
DRY POWDER DRUG FORMULATIONS
|
|
CA2460904C
(en)
|
2001-09-19 |
2011-03-22 |
Advent Pharmaceuticals Pty Ltd |
An inhaler for delivering metered doses of powdered medicament
|
|
GB0125132D0
(en)
*
|
2001-10-19 |
2001-12-12 |
Glaxo Group Ltd |
Medicament dispenser
|
|
GB0125135D0
(en)
*
|
2001-10-19 |
2001-12-12 |
Glaxo Group Ltd |
Medicament dispenser
|
|
GB0125134D0
(en)
*
|
2001-10-19 |
2001-12-12 |
Glaxo Group Ltd |
Medicament dispenser
|
|
GB0127989D0
(en)
*
|
2001-11-22 |
2002-01-16 |
Glaxo Group Ltd |
Medicament dispensing system
|
|
GB0130055D0
(en)
*
|
2001-12-14 |
2002-02-06 |
Technology Innovation Ltd |
Medicament packaging
|
|
EP1458360B1
(en)
*
|
2001-12-19 |
2011-05-11 |
Novartis AG |
Pulmonary delivery of aminoglycosides
|
|
GB0201677D0
(en)
*
|
2002-01-25 |
2002-03-13 |
Glaxo Group Ltd |
Medicament dispenser
|
|
GB0217199D0
(en)
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicament dispenser
|
|
WO2003061744A1
(en)
|
2002-01-25 |
2003-07-31 |
Glaxo Group Limited |
Medicament dispenser
|
|
AU2003216401A1
(en)
*
|
2002-03-01 |
2003-09-16 |
Glaxo Group Limited |
Rotary blending apparatus and system
|
|
WO2003074029A1
(en)
*
|
2002-03-07 |
2003-09-12 |
Vectura Limited |
Fast melt multiparticulate formulations for oral delivery
|
|
GB0205572D0
(en)
*
|
2002-03-09 |
2002-04-24 |
Chawla Brinda P S |
Medicament delivery and packaging
|
|
AU2003225973A1
(en)
*
|
2002-03-26 |
2003-11-11 |
Glaxo Group Limited |
A method for forming a laminate assembly and products formed thereby
|
|
GR1004350B
(el)
*
|
2002-03-29 |
2003-09-26 |
|
Συσκευη εισπνοων ξηρης σκονης
|
|
UA80123C2
(en)
*
|
2002-04-09 |
2007-08-27 |
Boehringer Ingelheim Pharma |
Inhalation kit comprising inhalable powder of tiotropium
|
|
US20030235538A1
(en)
*
|
2002-04-09 |
2003-12-25 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Method for the administration of an anticholinergic by inhalation
|
|
GB0208608D0
(en)
*
|
2002-04-13 |
2002-05-22 |
Glaxo Group Ltd |
Composition
|
|
GB0208609D0
(en)
*
|
2002-04-13 |
2002-05-22 |
Glaxo Group Ltd |
Compositions
|
|
US7271197B2
(en)
|
2002-04-25 |
2007-09-18 |
Glaxo Group Limited |
Phenethanolamine derivatives
|
|
US7429127B2
(en)
*
|
2002-04-25 |
2008-09-30 |
Glaxo Group Limited |
Magnetoacoustic sensor system and associated method for sensing environmental conditions
|
|
GB0209528D0
(en)
*
|
2002-04-26 |
2002-06-05 |
Glaxo Group Ltd |
Medicament dispenser
|
|
GB0209526D0
(en)
*
|
2002-04-26 |
2002-06-05 |
Glaxo Group Ltd |
Medicament dispenser
|
|
JP2005526261A
(ja)
*
|
2002-05-15 |
2005-09-02 |
グラクソ グループ リミテッド |
医薬包装内の温度および水分プロファイルを測定するための微小電気機械システムおよび方法
|
|
GB0216831D0
(en)
*
|
2002-07-19 |
2002-08-28 |
Glaxo Group Ltd |
Medicament dispenser
|
|
EP1534367A1
(en)
|
2002-07-25 |
2005-06-01 |
Glaxo Group Limited |
Medicament dispenser
|
|
GB0217225D0
(en)
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicinal compounds
|
|
GB0217198D0
(en)
*
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicament dispenser
|
|
EP1534368A1
(en)
*
|
2002-07-25 |
2005-06-01 |
Glaxo Group Limited |
Medicament dispenser
|
|
GB0217196D0
(en)
*
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicament dispenser
|
|
AU2003270602A1
(en)
*
|
2002-09-13 |
2004-04-30 |
Glaxo Group Limited |
Coated blending system
|
|
GB0221493D0
(en)
*
|
2002-09-17 |
2002-10-23 |
Glaxo Group Ltd |
Method for loading a medicament dispenser with a medicament carrier
|
|
US6962266B2
(en)
*
|
2002-10-04 |
2005-11-08 |
Ecolab Inc. |
Method and apparatus for using a unit dose dispenser
|
|
DE60315492T2
(de)
*
|
2002-10-22 |
2008-04-24 |
Glaxo Group Ltd., Greenford |
Medizinisch verwendbare arylethanolamin verbindungen
|
|
BR0315720A
(pt)
|
2002-10-28 |
2005-09-06 |
Glaxo Group Ltd |
Composto, método para a profilaxia ou tratamento de uma condição clìnica em um mamìmefero, formulação farmacêutica, combinação, uso de um composto, processo para a preparação de um composto, e, intermediário
|
|
WO2004060260A2
(en)
*
|
2002-12-18 |
2004-07-22 |
Glaxo Group Limited |
Drug delivery system with vented mouthpiece
|
|
US20040173211A1
(en)
*
|
2003-01-14 |
2004-09-09 |
Boehringer Ingelheim International Gmbh |
Powder inhaler
|
|
GB0303396D0
(en)
|
2003-02-14 |
2003-03-19 |
Glaxo Group Ltd |
Medicinal compounds
|
|
GB0303870D0
(en)
*
|
2003-02-20 |
2003-03-26 |
Norton Healthcare Ltd |
Pre-metered dose magazine for breath-actuated dry powder inhaler
|
|
DE602004028585D1
(de)
*
|
2003-03-15 |
2010-09-23 |
Brin Tech Internat Ltd |
Verpackung für Arzneimittel
|
|
DE10317461A1
(de)
|
2003-04-16 |
2004-10-28 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Radioaktiv markierte Mikropartikel, Verfahren zu deren Herstellung und deren Verwendung
|
|
TWI328009B
(en)
|
2003-05-21 |
2010-08-01 |
Glaxo Group Ltd |
Quinoline derivatives as phosphodiesterase inhibitors
|
|
SE527069C2
(sv)
*
|
2003-06-19 |
2005-12-13 |
Mederio Ag |
Förfarande och anordning för administrering av läkemedelspulver
|
|
GB0315509D0
(en)
|
2003-07-02 |
2003-08-06 |
Meridica Ltd |
Dispensing device
|
|
GB0316335D0
(en)
*
|
2003-07-11 |
2003-08-13 |
Glaxo Group Ltd |
Pharmaceutical formulations
|
|
PE20050250A1
(es)
|
2003-07-17 |
2005-04-08 |
Glaxo Group Ltd |
Antagonistas de los receptores muscarinicos de la acetilcolina
|
|
GB0317374D0
(en)
*
|
2003-07-24 |
2003-08-27 |
Glaxo Group Ltd |
Medicament dispenser
|
|
WO2005037280A1
(en)
|
2003-10-14 |
2005-04-28 |
Glaxo Group Limited |
Muscarinic acetycholine receptor antagonists
|
|
AU2004281167A1
(en)
|
2003-10-17 |
2005-04-28 |
Glaxo Group Limited |
Muscarinic acetylcholine receptor antagonists field of the invention
|
|
GB2407042B
(en)
|
2003-10-17 |
2007-10-24 |
Vectura Ltd |
Inhaler
|
|
GB0324654D0
(en)
*
|
2003-10-22 |
2003-11-26 |
Glaxo Group Ltd |
Medicinal compounds
|
|
GB0324897D0
(en)
*
|
2003-10-24 |
2003-11-26 |
Glaxo Group Ltd |
Composition
|
|
GB0324886D0
(en)
*
|
2003-10-24 |
2003-11-26 |
Glaxo Group Ltd |
Medicinal compounds
|
|
WO2005044187A2
(en)
*
|
2003-10-28 |
2005-05-19 |
Glaxo Group Limited |
Inhalable pharmaceutical formulations employing lactose anhydrate and methods of administering the same
|
|
PE20050489A1
(es)
|
2003-11-04 |
2005-09-02 |
Glaxo Group Ltd |
Antagonistas de receptores de acetilcolina muscarinicos
|
|
SE0303270L
(sv)
*
|
2003-12-03 |
2005-06-04 |
Microdrug Ag |
Metod för administration av tiotropium
|
|
SE0303570L
(sv)
*
|
2003-12-03 |
2005-06-04 |
Microdrug Ag |
Fukt-känslig medicinsk produkt
|
|
CA2547782A1
(en)
*
|
2003-12-03 |
2005-06-16 |
Microdrug Ag |
Medical product containing tiotropium
|
|
US7631812B2
(en)
*
|
2003-12-10 |
2009-12-15 |
Williams Troy P |
Foldable transaction card systems
|
|
GB0329182D0
(en)
|
2003-12-17 |
2004-01-21 |
Glaxo Group Ltd |
Chemical compounds
|
|
US20050172962A1
(en)
*
|
2004-02-06 |
2005-08-11 |
Microdose Technologies, Inc. |
Blister pack for use with an inhalation device
|
|
GB2410947B
(en)
*
|
2004-02-11 |
2008-09-17 |
Cambridge Lab Ltd |
Pharmaceutical compounds
|
|
NZ548888A
(en)
*
|
2004-02-16 |
2010-06-25 |
Glaxo Group Ltd |
Counter for use with a medicament dispenser
|
|
EP1725236A4
(en)
*
|
2004-03-11 |
2009-05-13 |
Glaxo Group Ltd |
NEW M3 MUSCARIN ACETYLCHOLINE RECEPTOR ANTAGONISTS
|
|
US7384946B2
(en)
|
2004-03-17 |
2008-06-10 |
Glaxo Group Limited |
M3 muscarinic acetylcholine receptor antagonists
|
|
US7846973B2
(en)
|
2004-04-02 |
2010-12-07 |
Theravance, Inc. |
Chemical process and new crystalline form
|
|
US7828147B2
(en)
*
|
2004-04-24 |
2010-11-09 |
Inrange Systems, Inc. |
Multi-layer medication carrier
|
|
US8019471B2
(en)
*
|
2004-04-24 |
2011-09-13 |
Inrange Systems, Inc. |
Integrated, non-sequential, remote medication management and compliance system
|
|
PE20060259A1
(es)
|
2004-04-27 |
2006-03-25 |
Glaxo Group Ltd |
Compuestos de quinuclidina como antagonistas del receptor de acetilcolina muscarinico
|
|
WO2005112644A2
(en)
|
2004-05-13 |
2005-12-01 |
Glaxo Group Limited |
Muscarinic acetylcholine receptor antagonists
|
|
PE20060272A1
(es)
|
2004-05-24 |
2006-05-22 |
Glaxo Group Ltd |
(2r,3r,4s,5r,2'r,3'r,4's,5's)-2,2'-{trans-1,4-ciclohexanodiilbis-[imino(2-{[2-(1-metil-1h-imidazol-4-il)etil]amino}-9h-purin-6,9-diil)]}bis[5-(2-etil-2h-tetrazol-5-il)tetrahidro-3,4-furanodiol] como agonista a2a
|
|
ES2257152B1
(es)
|
2004-05-31 |
2007-07-01 |
Laboratorios Almirall S.A. |
Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos.
|
|
PT1905451E
(pt)
|
2004-05-31 |
2010-03-31 |
Almirall Sa |
Combinações que compreendem agentes antimuscarínicos e corticosteróides
|
|
SE530006C2
(sv)
*
|
2004-06-18 |
2008-02-05 |
Mederio Ag |
Inhalator som använder balja
|
|
SE0401654D0
(sv)
*
|
2004-06-24 |
2004-06-24 |
Astrazeneca Ab |
A support structure for a medicament
|
|
FR2872798B1
(fr)
*
|
2004-07-09 |
2007-10-05 |
Valois Sas |
Ensemble de blisters pour dispositif d'inhalation
|
|
GB0418278D0
(en)
|
2004-08-16 |
2004-09-15 |
Glaxo Group Ltd |
Medicament dispenser
|
|
MX2007004106A
(es)
*
|
2004-10-06 |
2007-06-14 |
Boehringer Ingelheim Int |
Dispositivo dispensador, dispositivo de almacenamiento y metodo para dispensar polvo.
|
|
US20080042823A1
(en)
*
|
2004-11-12 |
2008-02-21 |
Heasley Matthew G |
Sensor System with Acoustic Transducer
|
|
GB0427853D0
(en)
*
|
2004-12-20 |
2005-01-19 |
Glaxo Group Ltd |
Manifold for use in medicament dispenser
|
|
GB0427858D0
(en)
*
|
2004-12-20 |
2005-01-19 |
Glaxo Group Ltd |
Manifold for use in medicament dispenser
|
|
GB0427856D0
(en)
*
|
2004-12-20 |
2005-01-19 |
Glaxo Group Ltd |
Maniflod for use in medicament dispenser
|
|
CA2594484A1
(en)
*
|
2005-01-11 |
2006-07-20 |
Glaxo Group Limited |
Cinnamate salts of a beta-2 adrenergic agonist
|
|
FR2881111B1
(fr)
*
|
2005-01-25 |
2010-07-30 |
Valois Sas |
Dispositif de distribution de produit fluide.
|
|
FR2881118B1
(fr)
*
|
2005-01-25 |
2007-04-20 |
Valois Sas |
Dispositif de distribution de produit fluide.
|
|
FR2881119B1
(fr)
*
|
2005-01-25 |
2010-07-30 |
Valois Sas |
Dispositif de distribution de produit fluide.
|
|
FR2881117B1
(fr)
*
|
2005-01-25 |
2010-07-30 |
Valois Sas |
Dispositif de distribution de produit fluide.
|
|
US20090029901A1
(en)
*
|
2005-02-10 |
2009-01-29 |
Marian Wood-Kaczmar |
Process for Crystallizing Lactose Particles for Use in Pharmaceutical Formulations
|
|
CN101155590A
(zh)
|
2005-02-10 |
2008-04-02 |
葛兰素集团有限公司 |
使用预分选技术制备乳糖的方法以及由此形成的药物制剂
|
|
PE20100741A1
(es)
|
2005-03-25 |
2010-11-25 |
Glaxo Group Ltd |
COMPUESTOS DERIVADOS DE 3,4-DIHIDROPIRIMIDO[4,5-d]PIRIMIDIN-2(1H)-ONA COMO INHIBIDORES DE QUINASA p38
|
|
TWI389690B
(zh)
|
2005-03-25 |
2013-03-21 |
Glaxo Group Ltd |
新穎化合物(一)
|
|
JP2008539839A
(ja)
*
|
2005-05-04 |
2008-11-20 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
複数回投与量の医薬組成物を含有する吸入装置
|
|
USD550350S1
(en)
*
|
2005-05-11 |
2007-09-04 |
Vectura Limited |
Pharmaceutical product
|
|
GB0509952D0
(en)
|
2005-05-16 |
2005-06-22 |
Glaxo Group Ltd |
Fault indicator
|
|
ES2265276B1
(es)
|
2005-05-20 |
2008-02-01 |
Laboratorios Almirall S.A. |
Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor beta2 adrenergico.
|
|
GB0514501D0
(en)
*
|
2005-07-14 |
2005-08-24 |
Cambridge Lab Ireland Ltd |
Pharmaceutical compounds
|
|
GB0514809D0
(en)
|
2005-07-19 |
2005-08-24 |
Glaxo Group Ltd |
Compounds
|
|
DE102005035705A1
(de)
|
2005-07-27 |
2007-02-01 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Arzneimittelblister
|
|
GB0515584D0
(en)
|
2005-07-28 |
2005-09-07 |
Glaxo Group Ltd |
Medicament dispenser
|
|
JP2009503101A
(ja)
*
|
2005-08-02 |
2009-01-29 |
グラクソ グループ リミテッド |
M3ムスカリン性アセチルコリン受容体アンタゴニスト
|
|
WO2007016639A2
(en)
*
|
2005-08-02 |
2007-02-08 |
Glaxo Group Limited |
M3 muscarinic acetylcholine receptor antagonists
|
|
GB0516168D0
(en)
*
|
2005-08-05 |
2005-09-14 |
Cambridge Lab Ireland Ltd |
Pharmaceutical compounds
|
|
JP2009504768A
(ja)
|
2005-08-18 |
2009-02-05 |
グラクソ グループ リミテッド |
ムスカリン性アセチルコリン受容体アンタゴニスト
|
|
TWI274641B
(en)
*
|
2005-08-30 |
2007-03-01 |
Rexon Ind Corp Ltd |
Cutting machine
|
|
US20070068837A1
(en)
*
|
2005-09-29 |
2007-03-29 |
D Angelis Bruno S |
Wound dressing dispenser
|
|
GB0521563D0
(en)
|
2005-10-21 |
2005-11-30 |
Glaxo Group Ltd |
Novel compounds
|
|
AR058290A1
(es)
*
|
2005-12-12 |
2008-01-30 |
Glaxo Group Ltd |
Dispensador de medicamento
|
|
AR058289A1
(es)
|
2005-12-12 |
2008-01-30 |
Glaxo Group Ltd |
Colector para ser usado en dispensador de medicamento
|
|
EP1986722B1
(en)
|
2006-01-31 |
2018-10-24 |
Oriel Therapeutics, Inc. |
Dry powder inhalers having spiral travel paths for microcartridges with dry powder
|
|
AU2007224178B2
(en)
*
|
2006-03-03 |
2013-03-07 |
Stc.Unm |
Dry powder inhaler with aeroelastic dispersion mechanism
|
|
US8127763B2
(en)
*
|
2006-03-03 |
2012-03-06 |
Stc.Unm |
Dry powder inhaler with aeroelastic dispersion mechanism
|
|
GB0605150D0
(en)
*
|
2006-03-14 |
2006-04-26 |
Glaxo Group Ltd |
Counter For Use With A Medicament Dispenser
|
|
EP1844808A1
(de)
*
|
2006-04-13 |
2007-10-17 |
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG |
Medikamenten-Ausgabevorrichtung
|
|
EP1844809A1
(de)
*
|
2006-04-13 |
2007-10-17 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Medikamentenmagazin für einen Inhalator, sowie Mehrdosispulverinhalator
|
|
CA2649509A1
(en)
|
2006-04-20 |
2007-11-01 |
Glaxo Group Limited |
Novel compounds
|
|
GR1005620B
(el)
*
|
2006-05-09 |
2007-09-03 |
|
Βελτιωση συσκευης εισπνοων ξηρης σκονης
|
|
GR1005668B
(el)
*
|
2006-05-09 |
2007-10-02 |
|
Συσκευη εισπνοων ξηρης σκονης για την ταυτοχρονη χορηγηση περισσοτερων απο μιας φαρμακευτικων ουσιων
|
|
US9457161B2
(en)
|
2006-05-18 |
2016-10-04 |
Boehringer Ingelheim International Gmbh |
Inhaler
|
|
DE102006023662A1
(de)
*
|
2006-05-18 |
2007-11-22 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Inhalator
|
|
GB0611587D0
(en)
|
2006-06-12 |
2006-07-19 |
Glaxo Group Ltd |
Novel compounds
|
|
FR2904229B1
(fr)
*
|
2006-07-25 |
2008-10-10 |
Valois Sas |
Dispositif de distribution de produit fluide.
|
|
US8003663B2
(en)
|
2006-08-01 |
2011-08-23 |
Glaxo Group Limited |
Pyrazolo[3,4-b]pyridine compounds, and their use as PDE4 inhibitors
|
|
CA2667225C
(en)
*
|
2006-10-25 |
2015-06-09 |
Novartis Ag |
Powder dispersion apparatus, method of making and using the apparatus, and components that can be used on the apparatus and other devices
|
|
GB0622827D0
(en)
|
2006-11-15 |
2006-12-27 |
Glaxo Group Ltd |
Sheet driver for use in a drug dispenser
|
|
EP1925295A1
(de)
|
2006-11-22 |
2008-05-28 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Stabile Pulverformulierung enthaltend ein Anticholinergikum
|
|
US8225784B2
(en)
*
|
2006-12-11 |
2012-07-24 |
Valois Sas |
Fluid product dispensing device
|
|
FR2909643B1
(fr)
*
|
2006-12-11 |
2011-03-04 |
Valois Sas |
Dispositif de distribution de produit fluide
|
|
US20080163610A1
(en)
*
|
2007-01-05 |
2008-07-10 |
Matthew Thomas Baird |
Method and system for regenerating exhaust system filtering and catalyst components using variable high engine idle
|
|
ES2306595B1
(es)
|
2007-02-09 |
2009-09-11 |
Laboratorios Almirall S.A. |
Sal de napadisilato de 5-(2-((6-(2,2-difluoro-2-feniletoxi)hexil)amino)-1-hidroxietil)-8-hidroxiquinolin-2(1h)-ona como agonista del receptor adrenergico beta2.
|
|
ES2320955B1
(es)
|
2007-03-02 |
2010-03-16 |
Laboratorios Almirall S.A. |
Nuevos derivados de 3-((1,2,4)triazolo(4,3-a)piridin-7-il)benzamida.
|
|
US8616199B2
(en)
|
2007-03-16 |
2013-12-31 |
Canon Kabushiki Kaisha |
Inhaler and ejection head unit attachable to the inhaler
|
|
PE20081889A1
(es)
|
2007-03-23 |
2009-03-05 |
Smithkline Beecham Corp |
Indol carboxamidas como inhibidores de ikk2
|
|
JP5198801B2
(ja)
*
|
2007-05-30 |
2013-05-15 |
株式会社吉野工業所 |
吸引式投薬器
|
|
US8496002B2
(en)
*
|
2007-06-12 |
2013-07-30 |
Civitas Therapeutics, Inc. |
Powder inhaler devices
|
|
EP2162174A1
(en)
*
|
2007-07-06 |
2010-03-17 |
Boehringer Ingelheim International GmbH |
Inhaler
|
|
EP2011536A1
(en)
*
|
2007-07-06 |
2009-01-07 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Inhaler
|
|
ES2569359T3
(es)
*
|
2007-07-06 |
2016-05-10 |
Vectura Delivery Devices Limited |
Inhalador
|
|
ES2320961B1
(es)
|
2007-11-28 |
2010-03-17 |
Laboratorios Almirall, S.A. |
Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor adrenergico beta2.
|
|
NZ586106A
(en)
|
2007-12-20 |
2012-09-28 |
Astrazeneca Ab |
Device, typically for medicament powder, for deaggregating powder by passing air stream along flat region with recess of brick shape where eddy is generated
|
|
RU2489173C2
(ru)
*
|
2008-01-23 |
2013-08-10 |
Астразенека Аб |
Дозатор лекарственных средств с дисплеем для отображения индикационных данных для пользователя
|
|
EP2082764A1
(en)
*
|
2008-01-24 |
2009-07-29 |
Boehringer Ingelheim International GmbH |
Inhaler
|
|
EP2082759A1
(en)
|
2008-01-24 |
2009-07-29 |
Boehringer Ingelheim International GmbH |
Inhaler
|
|
EP2082758A1
(en)
*
|
2008-01-24 |
2009-07-29 |
Boehringer Ingelheim International GmbH |
Inhaler
|
|
EP2096105A1
(en)
|
2008-02-28 |
2009-09-02 |
Laboratorios Almirall, S.A. |
Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the b2 adrenergic receptor
|
|
EP2100599A1
(en)
|
2008-03-13 |
2009-09-16 |
Laboratorios Almirall, S.A. |
Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
|
|
EP2100598A1
(en)
|
2008-03-13 |
2009-09-16 |
Laboratorios Almirall, S.A. |
Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
|
|
EP2108641A1
(en)
|
2008-04-11 |
2009-10-14 |
Laboratorios Almirall, S.A. |
New substituted spiro[cycloalkyl-1,3'-indo]-2'(1'H)-one derivatives and their use as p38 mitogen-activated kinase inhibitors
|
|
EP2113503A1
(en)
|
2008-04-28 |
2009-11-04 |
Laboratorios Almirall, S.A. |
New substituted indolin-2-one derivatives and their use as p39 mitogen-activated kinase inhibitors
|
|
GB0810857D0
(en)
*
|
2008-06-13 |
2008-07-23 |
Cambridge Lab Ireland Ltd |
Pharmaceutical compounds
|
|
WO2010008523A1
(en)
*
|
2008-07-13 |
2010-01-21 |
Map Pharmaceuticals, Inc. |
Methods and apparatus for delivering aerosolized medication
|
|
US20110053866A1
(en)
*
|
2008-08-12 |
2011-03-03 |
Biovail Laboratories International (Barbados) S.R.L. |
Pharmaceutical compositions
|
|
GB2462611A
(en)
*
|
2008-08-12 |
2010-02-17 |
Cambridge Lab |
Pharmaceutical composition comprising tetrabenazine
|
|
GB2463451A
(en)
|
2008-09-08 |
2010-03-17 |
Cambridge Lab |
3, 11b cis-dihydrotetrabenazine compounds for use in the treatment of dementia
|
|
GB2463452A
(en)
*
|
2008-09-08 |
2010-03-17 |
Cambridge Lab |
Desmethyl derivatives of tetrabenazine and pharmaceutical compositions thereof
|
|
GB2463283A
(en)
*
|
2008-09-08 |
2010-03-10 |
Cambridge Lab |
3,11b-cis-dihydrotetrabenazine for use in treating asthma
|
|
ES2570128T3
(es)
|
2008-09-26 |
2016-05-17 |
Oriel Therapeutics Inc |
Inhaladores con discos que tienen conductos de aire equipados con canales discretos de conductos de aire y discos y métodos relacionados
|
|
MX2011003232A
(es)
*
|
2008-09-26 |
2011-04-21 |
Oriel Therapeutics Inc |
Mecanismos inhaladaores con perforadores radialmente desviados y métodos relacionados.
|
|
WO2010036836A1
(en)
|
2008-09-26 |
2010-04-01 |
Oriel Therapeutics, Inc. |
Dry powder inhalers with dual piercing members and related devices and methods
|
|
WO2010039201A2
(en)
*
|
2008-09-30 |
2010-04-08 |
Oriel Therapeutics, Inc. |
Dry powder inhalers with multi-facet surface deagglomeration chambers and related devices and methods
|
|
MX2011003245A
(es)
*
|
2008-10-01 |
2011-04-26 |
Oriel Therapeutics Inc |
Inhaladores de polvo seco con mecanismos de perforacion giratorios y dispositivos y metodos relacionados.
|
|
BRPI0920671A2
(pt)
*
|
2008-10-08 |
2019-07-09 |
Astrazeneca Ab |
inalador com meio indicador audível
|
|
GB201020130D0
(en)
*
|
2010-11-26 |
2011-01-12 |
Vectura Delivery Devices Ltd |
Inhaler
|
|
EP2196465A1
(en)
|
2008-12-15 |
2010-06-16 |
Almirall, S.A. |
(3-oxo)pyridazin-4-ylurea derivatives as PDE4 inhibitors
|
|
EP2198908A1
(en)
*
|
2008-12-19 |
2010-06-23 |
Boehringer Ingelheim International Gmbh |
Inhaler
|
|
UY32297A
(es)
|
2008-12-22 |
2010-05-31 |
Almirall Sa |
Sal mesilato de 5-(2-{[6-(2,2-difluoro-2-fenilitoxi) hexil]amino}-1-hidroxietil)-8-hidroxiquinolin-2( 1h)-ona como agonista del receptor b(beta)2 acrenérgico
|
|
CN102348707A
(zh)
|
2009-01-13 |
2012-02-08 |
葛兰素集团有限公司 |
作为syk激酶抑制剂的嘧啶甲酰胺衍生物
|
|
NZ574666A
(en)
*
|
2009-02-05 |
2009-04-30 |
Nexus6 Ltd |
A medicament inhaler holder that uses optical means to count and display the number of doses used
|
|
WO2010094643A1
(en)
|
2009-02-17 |
2010-08-26 |
Glaxo Group Limited |
Quinoline derivatives and their uses for rhinitis and urticaria
|
|
EP2221055A1
(en)
|
2009-02-18 |
2010-08-25 |
Almirall, S.A. |
5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one for the treatment of lung function
|
|
EP2221297A1
(en)
|
2009-02-18 |
2010-08-25 |
Almirall, S.A. |
5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one and its use in the treatment of pulmonary diseases
|
|
ES2994042T3
(en)
|
2009-02-26 |
2025-01-16 |
Glaxo Group Ltd |
Pharmaceutical formulations comprising 4-{(1 r)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol
|
|
EP2226323A1
(en)
|
2009-02-27 |
2010-09-08 |
Almirall, S.A. |
New tetrahydropyrazolo[3,4-c]isoquinolin-5-amine derivatives
|
|
EP2228368A1
(en)
|
2009-03-12 |
2010-09-15 |
Almirall, S.A. |
Process for manufacturing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one
|
|
EP2421834A1
(en)
|
2009-04-24 |
2012-02-29 |
Glaxo Group Limited |
Pyrazole and triazole carboxamides as crac channel inhibitors
|
|
US8399436B2
(en)
|
2009-04-24 |
2013-03-19 |
Glaxo Group Limited |
N-pyrazolyl carboxamides as CRAC channel inhibitors
|
|
DE202009006141U1
(de)
|
2009-04-25 |
2009-08-27 |
Boehringer Ingelheim International Gmbh |
Inhalator
|
|
DK2427166T3
(da)
|
2009-05-07 |
2014-01-27 |
Gea Pharma Systems Ltd |
Tabletfremstillingsmodul og fremgangsmåde til kontinuerlig fremstilling af tabletter
|
|
US8910628B2
(en)
|
2009-05-18 |
2014-12-16 |
Norton Healthcare Limited |
Dry-powder inhaler
|
|
US8985102B2
(en)
|
2009-05-18 |
2015-03-24 |
Adamis Pharmaceuticals Corporation |
Dry powder inhalers
|
|
PL2432532T3
(pl)
|
2009-05-18 |
2015-01-30 |
Norton Healthcare Ltd |
Inhalator do suchego proszku
|
|
JP5667170B2
(ja)
|
2009-05-18 |
2015-02-12 |
ノートン・ヘルスケアー リミテッド |
ドライパウダー吸入器
|
|
EP3332826A1
(en)
|
2009-05-18 |
2018-06-13 |
Adamis Pharmaceuticals Corporation |
Dry powder inhaler with a dose counter
|
|
CN102438685B
(zh)
*
|
2009-05-21 |
2014-07-02 |
微剂量治疗技术公司 |
用于干粉吸入器的旋转盒系统
|
|
US8985101B2
(en)
|
2009-05-21 |
2015-03-24 |
Microdose Therapeutx, Inc. |
Method and device for clamping a blister within a dry powder inhaler
|
|
CA2764830A1
(en)
|
2009-06-16 |
2010-12-23 |
Schering Corporation |
Novel [3,2-c] heteroaryl steroids as glucocorticoid receptor agonists, compositions and uses thereof
|
|
EP2448623B1
(en)
|
2009-07-01 |
2017-12-20 |
AstraZeneca AB |
Dispenser and method for entraining powder in an airflow
|
|
WO2011129785A1
(en)
*
|
2010-04-13 |
2011-10-20 |
Mahmut Bilgic |
Dry powder inhaler mouthpiece button
|
|
GB0919431D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
|
US9360482B2
(en)
|
2009-11-05 |
2016-06-07 |
Glaxosmithkline Llc |
Process for the identification of a compound which inhibits the binding of the second bromodomain of each of human BRD-2, BRD-3, and BRD-4
|
|
GB0919434D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
|
US9102677B2
(en)
|
2009-11-05 |
2015-08-11 |
Glaxosmithkline Llc |
Benzodiazepine bromodomain inhibitor
|
|
GB0919423D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
|
GB0919426D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
|
ES2652304T3
(es)
|
2009-11-05 |
2018-02-01 |
Glaxosmithkline Llc |
Compuesto de benzodiacepina novedoso
|
|
GB0919432D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Use
|
|
EP2322176A1
(en)
|
2009-11-11 |
2011-05-18 |
Almirall, S.A. |
New 7-phenyl-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one derivatives
|
|
US9492625B2
(en)
|
2009-11-12 |
2016-11-15 |
Stc.Unm |
Dry powder inhaler with flutter dispersion member
|
|
GB0921075D0
(en)
|
2009-12-01 |
2010-01-13 |
Glaxo Group Ltd |
Novel combination of the therapeutic agents
|
|
TR200909791A2
(tr)
|
2009-12-25 |
2011-07-21 |
B�Lg�� Mahmut |
Salmeterol ve flutikazon içeren farmasötik bileşim@
|
|
CN104338219B
(zh)
|
2010-01-05 |
2017-10-24 |
微剂量治疗技术公司 |
吸入设备和方法
|
|
US8490795B2
(en)
|
2010-02-01 |
2013-07-23 |
Mallinckrodt Llc |
Container and method for facilitating disposal of unused pharmaceutical product
|
|
US9046403B2
(en)
*
|
2010-02-01 |
2015-06-02 |
Mallinckrodt Llc |
Systems and methods for managing use of a medicament
|
|
EP2380890A1
(en)
|
2010-04-23 |
2011-10-26 |
Almirall, S.A. |
New 7,8-dihydro-1,6-naphthyridin-5(6h)-one-derivatives as PDE4 inhibitors
|
|
GB201007203D0
(en)
|
2010-04-29 |
2010-06-16 |
Glaxo Group Ltd |
Novel compounds
|
|
EP2386555A1
(en)
|
2010-05-13 |
2011-11-16 |
Almirall, S.A. |
New cyclohexylamine derivatives having beta2 adrenergic agonist and m3 muscarinic antagonist activities
|
|
EP2394998A1
(en)
|
2010-05-31 |
2011-12-14 |
Almirall, S.A. |
3-(5-Amino-6-oxo-1,6-dihydropyridazin-3-yl)-biphenyl derivatives as PDE4 inhibitors
|
|
FR2961186B1
(fr)
*
|
2010-06-11 |
2012-07-13 |
Valois Sas |
Dispositif de distribution de produit fluide.
|
|
JP5844358B2
(ja)
|
2010-06-22 |
2016-01-13 |
グラクソスミスクライン エルエルシー |
ベンゾトリアゾロジアゼピン化合物を含むブロモドメイン阻害剤
|
|
FR2962345B1
(fr)
|
2010-07-09 |
2013-06-21 |
Valois Sas |
Inhalateur unidose de poudre seche pour blister pelable.
|
|
CN103118727B
(zh)
*
|
2010-07-21 |
2015-11-25 |
阿斯利康(瑞典)有限公司 |
吸入器
|
|
WO2012025473A1
(en)
|
2010-08-24 |
2012-03-01 |
Glaxo Group Limited |
Cc.chemokine receptor 4 antagonists
|
|
WO2012025474A1
(en)
|
2010-08-24 |
2012-03-01 |
Glaxo Group Limited |
Indazole compounds
|
|
ES2546422T5
(es)
|
2010-08-31 |
2023-01-20 |
Glaxosmithkline Ip Dev Ltd |
Productos medicinales de inhalación de polvo seco que presentan propiedades de control de la humedad y procedimientos de administración de los mismos
|
|
WO2012028662A1
(en)
|
2010-08-31 |
2012-03-08 |
Glaxo Group Limited |
Dry powder inhalation drug products exhibiting moisture control properties and methods of administering the same
|
|
EP2441755A1
(en)
|
2010-09-30 |
2012-04-18 |
Almirall, S.A. |
Pyridine- and isoquinoline-derivatives as Syk and JAK kinase inhibitors
|
|
JP2013544794A
(ja)
|
2010-10-21 |
2013-12-19 |
グラクソ グループ リミテッド |
アレルギー性障害、炎症性障害及び免疫障害に作用するピラゾール化合物
|
|
ES2532213T3
(es)
|
2010-10-21 |
2015-03-25 |
Glaxo Group Limited |
Compuestos de pirazol que actúan contra afecciones alérgicas, inmunitarias e inflamatorias
|
|
US9297813B2
(en)
|
2010-11-11 |
2016-03-29 |
Agency For Science, Technology And Research |
Targeting metabolic enzymes in human cancer
|
|
EP2457900A1
(en)
|
2010-11-25 |
2012-05-30 |
Almirall, S.A. |
New pyrazole derivatives having CRTh2 antagonistic behaviour
|
|
EP2463289A1
(en)
|
2010-11-26 |
2012-06-13 |
Almirall, S.A. |
Imidazo[1,2-b]pyridazine derivatives as JAK inhibitors
|
|
JP6050758B2
(ja)
|
2010-12-07 |
2016-12-21 |
レスピラ セラピューティクス インコーポレイテッドRespira Therapeutics,Inc. |
乾燥粉末吸入器及びその作動方法
|
|
EP2489663A1
(en)
|
2011-02-16 |
2012-08-22 |
Almirall, S.A. |
Compounds as syk kinase inhibitors
|
|
US20140005188A1
(en)
|
2011-03-11 |
2014-01-02 |
Glaxo Group Limited |
Pyrido[3,4-b]pyrazine derivatives as syk inhibitors
|
|
GB201104153D0
(en)
|
2011-03-11 |
2011-04-27 |
Glaxo Group Ltd |
Novel compounds
|
|
US8834411B2
(en)
|
2011-04-06 |
2014-09-16 |
Mystic Pharmaceuticals, Inc. |
Medical devices for dispensing powders
|
|
EP2510928A1
(en)
|
2011-04-15 |
2012-10-17 |
Almirall, S.A. |
Aclidinium for use in improving the quality of sleep in respiratory patients
|
|
GB201106750D0
(en)
|
2011-04-21 |
2011-06-01 |
Glaxosmithkline Llc |
Novel compounds
|
|
GB201106799D0
(en)
|
2011-04-21 |
2011-06-01 |
Glaxosmithkline Llc |
Novel compounds
|
|
GB201106743D0
(en)
|
2011-04-21 |
2011-06-01 |
Glaxosmithkline Llc |
Novel compounds
|
|
EP2518070A1
(en)
|
2011-04-29 |
2012-10-31 |
Almirall, S.A. |
Pyrrolotriazinone derivatives as PI3K inhibitors
|
|
EP2518071A1
(en)
|
2011-04-29 |
2012-10-31 |
Almirall, S.A. |
Imidazopyridine derivatives as PI3K inhibitors
|
|
GB201107325D0
(en)
|
2011-05-04 |
2011-06-15 |
Glaxosmithkline Llc |
Novel compounds
|
|
EP2527344A1
(en)
|
2011-05-25 |
2012-11-28 |
Almirall, S.A. |
Pyridin-2(1H)-one derivatives useful as medicaments for the treatment of myeloproliferative disorders, transplant rejection, immune-mediated and inflammatory diseases
|
|
EP2526945A1
(en)
|
2011-05-25 |
2012-11-28 |
Almirall, S.A. |
New CRTH2 Antagonists
|
|
BR112013031572A2
(pt)
|
2011-06-08 |
2017-03-21 |
Glaxo Group Ltd |
produto de combinação farmacêutica, e, inalador de pó seco.
|
|
RU2013153202A
(ru)
|
2011-06-08 |
2015-07-20 |
Глаксо Груп Лимитед |
Композиции для ингалятора сухого порошка, содержащие умеклидиний
|
|
EP2548863A1
(en)
|
2011-07-18 |
2013-01-23 |
Almirall, S.A. |
New CRTh2 antagonists.
|
|
EP2548876A1
(en)
|
2011-07-18 |
2013-01-23 |
Almirall, S.A. |
New CRTh2 antagonists
|
|
EP2554544A1
(en)
|
2011-08-01 |
2013-02-06 |
Almirall, S.A. |
Pyridin-2(1h)-one derivatives as jak inhibitors
|
|
GB201114103D0
(en)
|
2011-08-17 |
2011-09-28 |
Glaxosmithkline Llc |
Novel compounds
|
|
GB201116641D0
(en)
|
2011-09-27 |
2011-11-09 |
Glaxo Group Ltd |
Novel compounds
|
|
EP2578570A1
(en)
|
2011-10-07 |
2013-04-10 |
Almirall, S.A. |
Novel process for preparing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1(r)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one via novel intermediates of synthesis.
|
|
EP2592078A1
(en)
|
2011-11-11 |
2013-05-15 |
Almirall, S.A. |
New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities
|
|
EP2592077A1
(en)
|
2011-11-11 |
2013-05-15 |
Almirall, S.A. |
New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities
|
|
WO2013114371A1
(en)
|
2012-02-01 |
2013-08-08 |
Protalix Ltd. |
Dry powder formulations of dnase i
|
|
US10463815B2
(en)
|
2012-02-21 |
2019-11-05 |
Respira Therapeutics, Inc. |
Inhaler to deliver substances for prophylaxis or prevention of disease or injury caused by the inhalation of biological or chemical agents
|
|
GB2499597A
(en)
*
|
2012-02-21 |
2013-08-28 |
Innovata Biomed Ltd |
Dry powder inhaler with stepped rotation of metering member
|
|
US20150272988A1
(en)
|
2012-03-07 |
2015-10-01 |
Advanced Inhalation Therapies (Ait) Ltd. |
Inhalation of nitric oxide for treating respiratory diseases
|
|
EP2641900A1
(en)
|
2012-03-20 |
2013-09-25 |
Almirall, S.A. |
Novel polymorphic Crystal forms of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-(R)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one, heminapadisylate as agonist of the ß2 adrenergic receptor.
|
|
EP2647627A1
(en)
|
2012-04-02 |
2013-10-09 |
Almirall, S.A. |
Salts of 5-[(1r)-2-({2-[4-(2,2-difluoro-2-phenylethoxy)phenyl] ethyl}amino)-1-hydroxyethyl]-8-hydroxyquinolin-2(1h)-one.
|
|
DE102012104850A1
(de)
|
2012-04-05 |
2013-10-10 |
Alfred Von Schuckmann |
Vorrichtung zur portionierten Ausgabe von Medikamenten
|
|
JP6267685B2
(ja)
|
2012-04-13 |
2018-01-24 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited |
集合粒子
|
|
CN104379559B
(zh)
|
2012-04-27 |
2016-11-09 |
葛兰素集团有限公司 |
化合物
|
|
GB201207406D0
(en)
|
2012-04-27 |
2012-06-13 |
Glaxo Group Ltd |
Novel compounds
|
|
EP2662105B1
(de)
|
2012-05-09 |
2017-01-18 |
Boehringer Ingelheim International GmbH |
Zerstäuber
|
|
FR2990872B1
(fr)
|
2012-05-24 |
2015-05-15 |
Valois Sas |
Dispositif de distribution de produit fluide.
|
|
EP2666465A1
(en)
|
2012-05-25 |
2013-11-27 |
Almirall, S.A. |
Novel dosage and formulation
|
|
GB2502350A
(en)
|
2012-05-25 |
2013-11-27 |
Vectura Delivery Devices Ltd |
Inhaler having means to control the force applied to an actuating lever
|
|
WO2013176639A1
(en)
*
|
2012-05-25 |
2013-11-28 |
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi |
Inhaler device with an improved blister advancement mechanism
|
|
EA201492044A1
(ru)
*
|
2012-05-25 |
2015-05-29 |
Арвен Айлак Санайи Ве Тиджарет А.С. |
Ингалятор, содержащий внутренний корпус, имеющий канал для воздуха
|
|
EP2668941A1
(en)
|
2012-05-31 |
2013-12-04 |
Almirall, S.A. |
Novel dosage form and formulation of abediterol
|
|
KR20150030267A
(ko)
*
|
2012-07-05 |
2015-03-19 |
글락소 그룹 리미티드 |
흡입기 장치
|
|
WO2014060431A1
(en)
|
2012-10-16 |
2014-04-24 |
Almirall, S.A. |
Pyrrolotriazinone derivatives as pi3k inhibitors
|
|
EP2738172A1
(en)
|
2012-11-28 |
2014-06-04 |
Almirall, S.A. |
New bicyclic compounds as crac channel modulators
|
|
BR112015012312A2
(pt)
|
2012-11-28 |
2017-07-11 |
Intercept Pharmaceuticals Inc |
método de tratamento, redução do risco, prevenção ou alívio de uma afecção ou doença pulmonar em um sujeito; método de redução ou supressão de inflamação no pulmão em um sujeito; e método de promoção de reparo pulmonar em um sujeito
|
|
JP5350530B1
(ja)
*
|
2012-12-07 |
2013-11-27 |
ニップファーマ株式会社 |
薬剤吸入デバイス
|
|
BR112015013628A2
(pt)
|
2012-12-18 |
2017-07-11 |
Almirall Sa |
derivados de carbamato de ciclo-hexila e quinuclidinila tendo atividades agonista adrenérgica de beta2 e antagonista muscarínica de m3
|
|
AR094797A1
(es)
|
2013-02-15 |
2015-08-26 |
Almirall Sa |
Derivados de pirrolotriazina como inhibidores de pi3k
|
|
ES2704048T3
(es)
|
2013-03-14 |
2019-03-14 |
Glaxosmithkline Ip No 2 Ltd |
Derivados de 1-acil-4-amino-1,2,3,4-tetrahidroquinolina-2,3-disustituida y su uso como inhibidores de bromodominio
|
|
WO2014140077A1
(en)
|
2013-03-14 |
2014-09-18 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Furopyridines as bromodomain inhibitors
|
|
GB201305668D0
(en)
|
2013-03-28 |
2013-05-15 |
Glaxosmithkline Ip Dev Ltd |
Avs6 Integrin Antagonists
|
|
JP6105373B2
(ja)
*
|
2013-04-25 |
2017-03-29 |
株式会社吉野工業所 |
吸引器具
|
|
JP5985434B2
(ja)
*
|
2013-04-25 |
2016-09-06 |
株式会社吉野工業所 |
吸引器具
|
|
RU2544801C2
(ru)
*
|
2013-06-11 |
2015-03-20 |
Открытое Акционерное Общество "Фармацевтическая Фабрика Санкт-Петербурга" |
Порошковый ингалятор
|
|
EP2848615A1
(en)
|
2013-07-03 |
2015-03-18 |
Almirall, S.A. |
New pyrazole derivatives as CRAC channel modulators
|
|
USD737425S1
(en)
|
2013-07-09 |
2015-08-25 |
Celon Pharma S.A. |
Inhaler
|
|
USD746378S1
(en)
|
2013-07-30 |
2015-12-29 |
Celon Pharma S.A. |
Label for an inhaler
|
|
USD759163S1
(en)
|
2013-07-30 |
2016-06-14 |
Celon Pharma S.A. |
Label for an inhaler
|
|
CN103624401B
(zh)
*
|
2013-08-20 |
2016-03-02 |
南京理工大学 |
立式定量控制的自动爆炸复合炸药铺放装置
|
|
WO2015091285A1
(en)
|
2013-12-19 |
2015-06-25 |
Almirall S.A. |
Dosage formulation comprising salmeterol and fluticasone propionate
|
|
EA034279B1
(ru)
|
2013-12-23 |
2020-01-24 |
Гленмарк Фармасьютикалс Лтд |
Ингалятор сухого порошка
|
|
US20170100385A1
(en)
|
2014-05-12 |
2017-04-13 |
Glaxosmithkline Intellectual Property (No. 2) Limited |
Pharmaceutical compositions comprising danirixin for treating infectious diseases
|
|
ES2775606T3
(es)
|
2014-05-28 |
2020-07-27 |
Glaxosmithkline Ip Dev Ltd |
Furoato de fluticasona en el tratamiento de la EPOC
|
|
EP2957552B1
(en)
|
2014-06-16 |
2020-01-22 |
Arven Ilac Sanayi Ve Ticaret A.S. |
Vilanterol formulations
|
|
EP2957553A1
(en)
|
2014-06-16 |
2015-12-23 |
Arven Ilac Sanayi Ve Ticaret A.S. |
Pharmaceutical formulations of vilanterol
|
|
MA39288A
(fr)
|
2014-06-16 |
2015-12-23 |
Arven Ilac Sanayi Ve Ticaret As |
Formulations pharmaceutiques comprenant du vilanterol
|
|
TR201407010A2
(tr)
|
2014-06-16 |
2015-12-21 |
Arven Ilac Sanayi Ve Ticaret Anonim Sirketi |
Vilanterol formülasyonları.
|
|
WO2016057693A1
(en)
|
2014-10-10 |
2016-04-14 |
Alnylam Pharmaceuticals, Inc. |
Methods and compositions for inhalation delivery of conjugated oligonucleotide
|
|
US9550032B2
(en)
*
|
2014-10-12 |
2017-01-24 |
Kendra Baldwin |
Wearable wrist inhaler
|
|
CA2965759C
(en)
|
2014-10-31 |
2023-12-12 |
Glaxosmithkline Intellectual Property Development Limited |
Powdered polypeptides with decreased disulfide impurities comprising divalent cationic materials
|
|
EP3838317A1
(en)
|
2015-01-14 |
2021-06-23 |
Respira Therapeutics, Inc. |
Dry powder inhaler
|
|
GB201503720D0
(en)
|
2015-03-05 |
2015-04-22 |
Glaxosmithkline Ip No 2 Ltd |
Chemical compound
|
|
CN107428828A
(zh)
|
2015-03-11 |
2017-12-01 |
葛兰素史密斯克莱知识产权发展有限公司 |
Tslp结合蛋白
|
|
USD767114S1
(en)
|
2015-03-18 |
2016-09-20 |
Amneal Pharmaceuticals Company Gmbh |
Inhalation device
|
|
USD769439S1
(en)
|
2015-03-18 |
2016-10-18 |
Amneal Pharmaceuticals Company Gmbh |
Inhalation device
|
|
GB201504689D0
(en)
|
2015-03-19 |
2015-05-06 |
Glaxosmithkline Ip Dev Ltd |
Chemical compounds
|
|
CN106139335B
(zh)
*
|
2015-04-09 |
2022-12-16 |
正大天晴药业集团股份有限公司 |
一种药粉释放装置
|
|
WO2016161830A1
(zh)
*
|
2015-04-09 |
2016-10-13 |
正大天晴药业集团股份有限公司 |
药物释放带
|
|
TWI597079B
(zh)
*
|
2015-04-10 |
2017-09-01 |
微劑量醫療公司 |
泡殼帶進給機構
|
|
EP3286178A1
(en)
|
2015-04-21 |
2018-02-28 |
Almirall S.A. |
Amino-substituted heterocyclic derivatives as sodium channel inhibitors
|
|
AU364719S
(en)
|
2015-05-20 |
2015-10-14 |
Korea United Pharm Inc |
Medicine inhaler
|
|
US10604509B2
(en)
|
2015-06-15 |
2020-03-31 |
Glaxosmithkline Intellectual Property Development Limited |
Nrf2 regulators
|
|
US20180179167A1
(en)
|
2015-06-15 |
2018-06-28 |
Glaxosmithkline Intellectual Property Development Limited |
Nrf2 REGULATORS
|
|
ES2834490T3
(es)
|
2015-06-15 |
2021-06-17 |
Glaxosmithkline Ip Dev Ltd |
Reguladores de NRF2
|
|
WO2016202800A1
(en)
|
2015-06-16 |
2016-12-22 |
Almirall, S.A. |
Pyrrolotriazinone derivatives as pi3k inhibitors
|
|
CN107614037B
(zh)
*
|
2015-07-29 |
2021-09-03 |
正大天晴药业集团股份有限公司 |
药物释放带
|
|
TW201722965A
(zh)
|
2015-08-16 |
2017-07-01 |
葛蘭素史密斯克藍智慧財產發展有限公司 |
用於抗菌應用之化合物
|
|
JP6795588B2
(ja)
|
2015-09-22 |
2020-12-02 |
グラクソスミスクライン、インテレクチュアル、プロパティー、(ナンバー2)、リミテッドGlaxosmithkline Intellectual Property (No.2) Limited |
ブロモドメイン阻害薬としての使用のためのピリジノンジカルボキサミド
|
|
EP3371167A1
(en)
|
2015-10-06 |
2018-09-12 |
GlaxoSmithKline Intellectual Property Development Limited |
Arylcyclohexyl pyrazoles as nrf2 regulators
|
|
US10364256B2
(en)
|
2015-10-06 |
2019-07-30 |
Glaxosmithkline Intellectual Property Development Limited |
Biaryl pyrazoles as NRF2 regulators
|
|
AU2016357651A1
(en)
|
2015-11-18 |
2018-05-17 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Pharmaceutical compositions of ribavirin
|
|
GB201604680D0
(en)
|
2016-03-21 |
2016-05-04 |
Glaxosmithkline Ip Dev Ltd |
Chemical Compounds
|
|
AU2017245641A1
(en)
|
2016-04-07 |
2018-09-13 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Pyridyl derivatives as bromodomain inhibitors
|
|
WO2017174620A1
(en)
|
2016-04-07 |
2017-10-12 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Benzo[b]furans as bromodomain inhibitors
|
|
WO2017176291A1
(en)
*
|
2016-04-08 |
2017-10-12 |
Kendra Baldwin T |
Wearable wrist inhaler
|
|
CN109153646B
(zh)
|
2016-05-24 |
2022-08-02 |
葛兰素史克知识产权第二有限公司 |
作为溴结构域抑制剂的吡啶二甲酰胺衍生物
|
|
GB201614934D0
(en)
|
2016-09-02 |
2016-10-19 |
Glaxosmithkline Intellectual Property (No 2) Ltd |
Chemical compounds
|
|
GB201614940D0
(en)
|
2016-09-02 |
2016-10-19 |
Glaxosmithkline Intellectual Property (No 2) Ltd |
Chemical compounds
|
|
GB201614939D0
(en)
|
2016-09-02 |
2016-10-19 |
Glaxosmithkline Ip Dev Ltd |
Crystalline hydrate
|
|
ES2877763T3
(es)
|
2016-09-20 |
2021-11-17 |
Glaxosmithkline Ip No 2 Ltd |
Antagonistas del trpv4
|
|
TW201825458A
(zh)
|
2016-09-20 |
2018-07-16 |
英商葛蘭素史克智慧財產(第二)有限公司 |
Trpv4拮抗劑
|
|
JP2019532054A
(ja)
|
2016-09-20 |
2019-11-07 |
グラクソスミスクライン、インテレクチュアル、プロパティー、(ナンバー2)、リミテッドGlaxosmithkline Intellectual Property (No.2) Limited |
Trpv4拮抗薬
|
|
CN109045428B
(zh)
*
|
2016-10-03 |
2021-06-29 |
捷普科技(上海)有限公司 |
药剂分配器
|
|
WO2018094392A1
(en)
|
2016-11-21 |
2018-05-24 |
Lupin Inc. |
Medicament dispenser
|
|
WO2018104766A1
(en)
|
2016-12-06 |
2018-06-14 |
Glaxosmithkline Intellectual Property Development Limited |
3-(2,3-dihydro-1h-inden-5-yl)propanoic acid derivatives and their use as nrf2 regulators
|
|
WO2018109641A1
(en)
|
2016-12-12 |
2018-06-21 |
Glaxosmithkline Intellectual Property Development Limited |
3-carboxylic acid pyrroles as nrf2 regulators
|
|
EP3551621A1
(en)
|
2016-12-12 |
2019-10-16 |
GlaxoSmithKline Intellectual Property Development Limited |
N-aryl pyrazoles as nrf2 regulators
|
|
WO2018109647A1
(en)
|
2016-12-14 |
2018-06-21 |
Glaxosmithkline Intellectual Property Development Limited |
Bisaryl amides as nrf2 regulators
|
|
US20220002272A1
(en)
|
2016-12-14 |
2022-01-06 |
Glaxosmithkline Intellectual Property Development Limited |
Bisaryl lactams as nrf2 activators
|
|
EP3555078B1
(en)
|
2016-12-14 |
2024-03-27 |
GlaxoSmithKline Intellectual Property Development Limited |
Bisaryl heterocycles as nrf2 activators
|
|
US11059816B2
(en)
|
2016-12-15 |
2021-07-13 |
Glaxosmithkline Intellectual Property Development Limited |
Ether linked triazoles as NRF2 activators
|
|
KR20190091455A
(ko)
|
2016-12-15 |
2019-08-06 |
글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 |
Nrf2 화합물
|
|
US10702495B2
(en)
|
2017-02-20 |
2020-07-07 |
Nexien Biopharma, Inc. |
Method and compositions for treating dystrophies and myotonia
|
|
GB201703282D0
(en)
|
2017-03-01 |
2017-04-12 |
Glaxosmithkline Intellectual Property (No 2) Ltd |
Compounds
|
|
CN108622469B
(zh)
*
|
2017-03-24 |
2023-08-15 |
李和伟 |
一种独立包装的履带式给药器
|
|
CA3057778A1
(en)
|
2017-03-31 |
2018-10-04 |
Glaxosmithkline Intellectual Property Development Limited |
Immunogenic composition, use and method of treatment
|
|
TWI778052B
(zh)
|
2017-04-24 |
2022-09-21 |
美商共結晶製藥公司 |
流感病毒複製之抑制劑
|
|
EP3658211B1
(en)
|
2017-07-25 |
2022-09-28 |
Adherium (NZ) Limited |
Adherence monitoring method and device
|
|
TW201919682A
(zh)
|
2017-08-08 |
2019-06-01 |
西班牙商阿爾米雷爾有限公司 |
活化Nrf2路徑的新穎化合物
|
|
GB201716392D0
(en)
|
2017-10-06 |
2017-11-22 |
Glaxosmithkline Intellectual Property (No 2) Ltd |
Compounds
|
|
GB201716369D0
(en)
|
2017-10-06 |
2017-11-22 |
Glaxosmithkline Intellectual Property (No 2) Ltd |
Compounds
|
|
US20210177861A1
(en)
|
2017-12-11 |
2021-06-17 |
Glaxosmithkline Intellectual Property Development Limited |
Nrf2 activator for the treatment of acute lung injury, acute respiratory distress syndrome and multiple organ dysfunction syndrome
|
|
WO2019116231A1
(en)
|
2017-12-11 |
2019-06-20 |
Glaxosmithkline Intellectual Property Development Limited |
Nrf2 activator for the treatment of acute lung injury, acute respiratory distress syndrome and multiple organ dysfunction syndrome
|
|
GB201720989D0
(en)
|
2017-12-15 |
2018-01-31 |
Glaxosmithkline Ip Dev Ltd |
Chemical compounds
|
|
TWI795510B
(zh)
|
2018-01-17 |
2023-03-11 |
英商葛蘭素史密斯克藍智慧財產發展有限公司 |
PI4KIIIβ抑制劑
|
|
CN110237373B
(zh)
*
|
2018-03-08 |
2023-06-02 |
润生药业有限公司 |
一种生产用于联合用药的药物载体的装置及方法
|
|
WO2019195711A1
(en)
|
2018-04-06 |
2019-10-10 |
Lupin Inc. |
Medicament dispenser
|
|
US11643407B2
(en)
|
2018-05-23 |
2023-05-09 |
Glaxosmithkline Intellectual Property Development Limited |
Indanes as NRF2 activators
|
|
EP3829719B1
(en)
|
2018-07-27 |
2025-04-02 |
Cocrystal Pharma, Inc. |
Pyrrolo[2,3-b]pyridin derivatives as inhibitors of influenza virus replication
|
|
GB201812671D0
(en)
|
2018-08-03 |
2018-09-19 |
Coalesce Product Dev Ltd |
An inhaler device
|
|
GB201814167D0
(en)
|
2018-08-31 |
2018-10-17 |
Glaxosmithkline Ip No 2 Ltd |
Compounds
|
|
EP3840803A4
(en)
|
2018-09-10 |
2022-05-18 |
Cipla Limited |
Single blister-strip based dispenser
|
|
TWI844564B
(zh)
|
2018-09-10 |
2024-06-11 |
美商共結晶製藥公司 |
流感病毒複製之抑制劑
|
|
AU2019361038B2
(en)
|
2018-10-17 |
2025-07-03 |
Cocrystal Pharma, Inc. |
Combinations of inhibitors of influenza virus replication
|
|
US12156876B2
(en)
|
2018-11-13 |
2024-12-03 |
Cocrystal Pharma, Inc. |
Formulations of influenza therapeutics
|
|
EP3887355A1
(en)
|
2018-11-26 |
2021-10-06 |
Cocrystal Pharma, Inc. |
Inhibitors of influenza virus replication
|
|
US11458098B2
(en)
|
2019-04-29 |
2022-10-04 |
Insmed Incorporated |
Dry powder compositions of treprostinil prodrugs and methods of use thereof
|
|
EP3750528A1
(en)
|
2019-06-11 |
2020-12-16 |
Nexien Biopharma, Inc. |
Compositions for treating dystrophies and myotonia
|
|
GB201908536D0
(en)
|
2019-06-13 |
2019-07-31 |
Glaxosmithkline Ip Dev Ltd |
Compounds
|
|
US12139282B2
(en)
|
2020-03-06 |
2024-11-12 |
Vectura Delivery Devices Limited |
Process for manufacturing a blister strip for a dry powder inhaler
|
|
US20230151034A1
(en)
|
2020-03-17 |
2023-05-18 |
Cocrystal Pharma, Inc. |
Peptidomimetic n5-methyl-n2-(nonanoyl-l-leucyl)-l-glutaminate derivatives, triazaspiro[4.14]nonadecane derivatives and similar compounds as inhibitors of norovirus and coronavirus replication
|
|
EP4126139A1
(en)
|
2020-03-25 |
2023-02-08 |
Lupin Inc. |
Multi-carrier medicament dispensers
|
|
CN115698035A
(zh)
|
2020-04-10 |
2023-02-03 |
共晶制药公司 |
诺如病毒及冠状病毒复制的抑制剂
|
|
EP4138884A1
(en)
|
2020-04-20 |
2023-03-01 |
Sorrento Therapeutics, Inc. |
Pulmonary administration of ace2 polypeptides
|
|
DK4061457T3
(da)
|
2020-06-15 |
2025-02-03 |
Norton Waterford Ltd |
Inhalator omfattende en blisterpakning
|
|
PL244222B1
(pl)
|
2020-09-24 |
2023-12-18 |
Polfarmex Spolka Akcyjna |
Inhalator do podawania leku
|
|
PL244221B1
(pl)
|
2020-09-24 |
2023-12-18 |
Polfarmex Spolka Akcyjna |
Inhalator do podawania leku
|
|
JP2024510717A
(ja)
|
2021-02-22 |
2024-03-11 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
免疫原性組成物、使用及び方法
|
|
WO2022175425A1
(en)
|
2021-02-22 |
2022-08-25 |
Glaxosmithkline Intellectual Property Development Limited |
Inhaled mtor kinase inhibitors for use in the treatment or the prevention of a respiratory rna virus infection
|
|
WO2022179967A1
(en)
|
2021-02-23 |
2022-09-01 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Vadadustat for treating covid-19 in a hospitalized subject
|
|
US20240398757A1
(en)
|
2021-08-03 |
2024-12-05 |
Cocrystal Pharma, Inc. |
Inhibitors for coronaviruses
|
|
GB202111658D0
(en)
|
2021-08-13 |
2021-09-29 |
Norton Waterford Ltd |
Dry powder medicament inhaler
|
|
ES2981159T3
(es)
|
2021-08-13 |
2024-10-07 |
Norton Waterford Ltd |
Inhalador de medicamento de polvo seco
|
|
PT4221793T
(pt)
|
2021-09-29 |
2025-05-26 |
Norton Waterford Ltd |
Inalador de medicamento em pó seco
|
|
AU2022358453C1
(en)
|
2021-09-29 |
2025-09-18 |
Norton (Waterford) Limited |
Dry powder medicament inhaler
|
|
FI4221793T3
(fi)
|
2021-09-29 |
2025-06-02 |
Norton Waterford Ltd |
Kuivajauhelääkeinhalaattori
|
|
GB202113921D0
(en)
|
2021-09-29 |
2021-11-10 |
Norton Waterford Ltd |
Dry powder medicament inhaler
|
|
CN114178071B
(zh)
*
|
2021-12-10 |
2022-09-09 |
杭州博乐工业设计股份有限公司 |
一种可更换储液设备的喷雾器
|
|
WO2023150747A1
(en)
|
2022-02-07 |
2023-08-10 |
Insmed Incorporated |
Dry powder compositions of bedaquiline and salts and methods of use thereof
|
|
GB2618145A
(en)
*
|
2022-04-29 |
2023-11-01 |
Merxin Ltd |
Manifold
|
|
EP4591907A3
(en)
|
2024-01-23 |
2025-09-10 |
Zeteo Biomedical LLC |
Multi-chambered powder dispense system
|